Teva shareholders elect board, approve executive compensation and auditor at annual meeting

TEVA PHARMACEUTICAL INDUSTRIES LTD

Chen Lichtenstein elected to board until 2027; Amir Elstein, Roberto Mignone, Perry Nisen, Tal Zaks elected until 2028.
Non-binding advisory vote on executive compensation approved with 688.8M for vs 99.2M against.
Amended compensation policy for executives and directors approved with 710.2M for.
Reappointment of Kesselman & Kesselman (PwC) as auditor approved with 820.2M for.
All proposals passed with substantial majorities; no material dissent reported.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.